← Browse by Condition
Medical Condition

pediatric sarcoma refractory

Total Trials
1
Recruiting Now
1
Trial Phases
Phase 1, Phase 2
NCT05634369 Phase 1, Phase 2
Recruiting

A Multi-Institution Study of TGFβ Imprinted, Ex Vivo Expanded Universal Donor NK Cell Infusions as Adoptive Immunotherapy in Combination With Gemcitabine and Docetaxel in Patients With Relapsed or Refractory Pediatric Bone and Soft Tissue

Enrollment
50 pts
Location
United States
Sponsor
Nationwide Children's Hospital
View Trial →